Global /India /Healthcare /Biotechnology /BLUEJET
chevron_leftBack

Blue Jet Healthcare Ltd.

BLUEJET
NSE: BLUEJET Delayed
745.20INR -0.7%
8.72 USD
As of 24 April 2025, Blue Jet Healthcare Ltd. has a market cap of $1.53B USD, ranking #6348 globally and #438 in India. It ranks #596 in the Healthcare sector, and #150 in the Biotechnology industry.
Global Rank
6348
Country Rank
438
Sector Rank
596
Industry Rank
150
Key Stats
Market Cap
$1.53BUSD
130.19B INR
Enterprise Value
$1.48BUSD
126.55B INR
Revenue (TTM)
$102.36MUSD
8.73B INR
EBITDA (TTM)
$34.6MUSD
2.96B INR
Net Income (TTM)
$27.51MUSD
2.35B INR
EBITDA Margin
34%
Profit Margin
27%
PE Ratio
55.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Shiven Arora open_in_new
Employees
447
Founded
1968
Website
bluejethealthcare.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.7% 1.9% -17% 29% 50% 91%
Upcoming Earnings
Earnings Date
Fri, May 30

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
BLUEJET
Blue Jet Healthcare Ltd
ISIN: INE0KBH01020
Shares Out.:
173.465M1 Shares Float: 22.456M2
TV:
SA:
YF:
GF:
BA:
MS:
745.20 INR
Bombay Stock Exchange
MIC: XBOM
544009 (BLUEJET)
Blue Jet Healthcare Ltd
ISIN: INE0KBH01020
TV:
SA:
YF:
GF:
BA:
MS:
748.60 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Blue Jet Healthcare Ltd.

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, Spain, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

Similar Companies

Industry: Biotechnology (India)
Name
Market Cap diff.
Biocon Ltd.
BIOCON
$4.68B
399.49B INR
207%
Concord Biotech Ltd.
CONCORDBIO
$2.06B
175.62B INR
35%
OneSource Specialty Pharma Ltd.
ONESOURCE
$2.04B
174.49B INR
34%
Supriya Lifescience Ltd.
SUPRIYA
$686.26M
58.56B INR
-55%
Dishman Carbogen Amcis Ltd.
DCAL
$390.62M
33.33B INR
-74%
Industry: Biotechnology (Global)
Name
Market Cap diff.
Vertex Pharmaceuticals Inc.
VRTX
$126.59B
8K%
CSL Ltd.
CSL
$74.13B
116.09B AUD
5K%
Regeneron Pharmaceuticals, Inc.
REGN
$62.91B
4K%
Samsung Biologics Co.,Ltd.
207940
$52.85B
75.87T KRW
3K%
argenx SE
ARGX
$36.51B
32.22B EUR
2K%